Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2021
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of net sales

 

 

Three Months Ended

 

March 31,

 

 

2021

 

 

2020

 

Sales/access fees

 

$

-

 

 

$

8,250

 

Distribution rights income

 

 

9,125

 

 

 

28,645

 

Membership/program fees

 

 

999

 

 

 

-

 

Net sales

 

$

10,124

 

 

$

36,895

 

Schedule of changes in deferred revenue

Balance as of December 31, 2020

 

 

 

Short term

 

$

63,331

 

Long term

 

 

72,281

 

Total as of December 31, 2020

 

$

135,612

 

Cash payments received

 

 

1,499

Reclass to deferred grant

 

 

(28,350

)

Net sales recognized

 

 

(10,124

)

Balance as of March 31, 2021

 

 

98,637

 

Less short term

 

 

34,981

 

Long term

 

$

63,656

 

Schedule of computations of weighted average shares outstanding

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2021

 

 

2020

 

Shares underlying options outstanding

 

$

818,631

 

 

$

822,797

 

Shares underlying warrants outstanding

 

 

72,500

 

 

 

72,500

 

Convertible preferred stock outstanding

 

 

240,000

 

 

 

240,000

 

 

 

$

1,131,131

 

 

$

1,135,297